Open Access

Expression of yes‑associated protein, β‑catenin and smoothened, and their clinical significance in invasive breast cancer

  • Authors:
    • Pengju Liu
    • Jianfeng Zeng
    • Gaohua Yang
  • View Affiliations

  • Published online on: May 6, 2022     https://doi.org/10.3892/etm.2022.11356
  • Article Number: 429
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The expression profile and role of yes‑associated protein (YAP) in occurrence and development of breast cancer is ambiguous. The present study aimed to explore the relationship among the YAP, β‑catenin and smoothened (SMO) signaling pathways to provide a theoretical basis for the clinical diagnosis and treatment of invasive breast cancer. Immunohistochemistry was used to determine the protein expression levels of YAP, β‑catenin and SMO in tumor, tumor‑adjacent and normal breast tissue. The possible association between the expression levels of these three proteins and the clinicopathological features of patients with breast cancer was then analyzed by the χ2 test. The protein expression of YAP was found to be downregulated, whilst β‑catenin and SMO expression were found to be upregulated in tumor tissues as compared with that in normal breast tissues. In addition, the expression of YAP in breast cancer tissues was found to be associated with that of human epidermal growth factor receptor 2 (HER2), progesterone and estrogen receptors. By contrast, the protein expression of β‑catenin and SMO in breast cancer tissues was only associated with HER2. There was a negative correlation between the expression of YAP and SMO protein in breast cancer tissues. Compared with that in the changes in each of YAP, β‑catenin and SMO protein expression levels individually, their combined changes in expression were demonstrated to associate significantly with the tumor histological grade. To conclude, data from the present study suggest that the combined protein expression of YAP, β‑catenin and SMO can be used as a prognostic indicator for the treatment of invasive breast cancer.

Related Articles

Journal Cover

June-2022
Volume 23 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu P, Zeng J and Yang G: Expression of yes‑associated protein, β‑catenin and smoothened, and their clinical significance in invasive breast cancer. Exp Ther Med 23: 429, 2022
APA
Liu, P., Zeng, J., & Yang, G. (2022). Expression of yes‑associated protein, β‑catenin and smoothened, and their clinical significance in invasive breast cancer. Experimental and Therapeutic Medicine, 23, 429. https://doi.org/10.3892/etm.2022.11356
MLA
Liu, P., Zeng, J., Yang, G."Expression of yes‑associated protein, β‑catenin and smoothened, and their clinical significance in invasive breast cancer". Experimental and Therapeutic Medicine 23.6 (2022): 429.
Chicago
Liu, P., Zeng, J., Yang, G."Expression of yes‑associated protein, β‑catenin and smoothened, and their clinical significance in invasive breast cancer". Experimental and Therapeutic Medicine 23, no. 6 (2022): 429. https://doi.org/10.3892/etm.2022.11356